Current Edition


Shkreli’s former company Vyera settles for $40M in antitrust case, but ‘pharma bro’ still faces his own trials

A fraud conviction and seven-year prison sentence haven’t spared “Pharma Bro” and Wu-Tang Clan enthusiast Martin Shkreli from a federal antitrust lawsuit tied to his …

Continue Reading →

Lawmakers blast pharma for ‘outrageous’ prices and ‘anticompetitive conduct’ in culmination of 3-year probe

For years, drugmakers have targeted “weaknesses” in the U.S. healthcare system to reap dividends on older meds, The House Oversight Committee said Friday. The “outrageous …

Continue Reading →